Plants are frequently discussed as possible sources of novel drugs, and in recent years they have been investigated as potential sources of medicinal therapeutic agents including novel anti-cancerous agents. Solanum incanum was found to have anti-cancer activity against different stages of carcinoma development.
G&E offers customized solutions for extractions from Solanum incanum in Taiwan. All processings of plant materials are regulated from begining of cultivation which has been developed as a line of standard operations through seedlings and harvesting.
The collected plant material from seeds to harvest are carefully handled to avoid contamination with airborne pathogens; this environmental protection norms laid down by the regulatory bodies. Heavy metals & pesticide residues analysis is also carefully determined to ensure the overall dimensios in compliance to FDA regulatory agency requirements, this is designed to manage risks associated with the conversion of scientific discoveries to new products & processes and eventual launch on to the market.